1-1 of 1
Michele Maharaj, RN, OCN, CCRP
Close
Sort by
Journal Articles

Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, MD, Patrick J. Stiff, MD, Michele Maharaj, RN, OCN, CCRP, Katherine Oliver, BS, CCRP, Natalie Scott Callander, MD
Journal: Blood
Blood (2016) 128 (22): 4485.
https://doi.org/10.1182/blood.V128.22.4485.4485
Published: 2016